GAD2 and type 1 diabetes mellitus: Previous studies have predominantly identified GAD65 and IA-2 to be the target islet antigens recognised by CD4+ T cells or T cell clones from individuals with type 1 diabetes using the HLA-DR3 and -DQ2 restriction elements [4].